 
        Platelet-Rich Plasma vs. Corticosteroid for Chronic Plantar Fasciitis: A Randomized Trial
 
                                                    Platelet-Rich Plasma vs. Corticosteroid for Chronic Plantar Fasciitis: A Randomized Trial
Comparative study of local injections of autologous platelet rich plasma versus corticosteroid in management of chronic plantar fasciitis.
J Clin Orthop Trauma. 2023 Jul 17;43:102225.Synopsis
70 patients with chronic plantar fasciitis were randomized to receive a platelet-rich plasma (PRP) injection (n=35) or a corticosteroid injection (n=35). The primary outcome of interest was pain, as measured on a Visual Analog Scale (VAS) and the American Orthopaedic Foot and Ankle Society (AOFAS) score. Outcomes were assessed at 15 days, and 1, 3, and 6 months post-injection. The results revealed...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.